We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Show more
- Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the first quarter of 2024; updated combination data expected...
– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired...
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.96 | 9.77596741344 | 9.82 | 11.62 | 9.74 | 336562 | 10.83156085 | CS |
4 | 1.67 | 18.3315038419 | 9.11 | 11.62 | 8.71 | 292289 | 9.9625014 | CS |
12 | 1.74 | 19.2477876106 | 9.04 | 11.62 | 8.06 | 333262 | 9.36623129 | CS |
26 | 9.14 | 557.317073171 | 1.64 | 11.62 | 1.575 | 1000235 | 6.47083788 | CS |
52 | 7.85 | 267.918088737 | 2.93 | 11.62 | 1.3301 | 514963 | 6.31159374 | CS |
156 | -26.82 | -71.329787234 | 37.6 | 37.6 | 1.3301 | 282832 | 8.17922417 | CS |
260 | -7.83 | -42.0741536808 | 18.61 | 60.5162 | 1.3301 | 266679 | 11.11439889 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions